LeandroJonatad1 Profile Banner
Leandro Jonata Oliveira Profile
Leandro Jonata Oliveira

@LeandroJonatad1

Followers
875
Following
7K
Statuses
405

Medical Oncologist at Grupo Oncoclínicas. Focused on Breast Cancer and Cancer Genetics 🧬. Tweets are my own.

São Paulo - 🇧🇷
Joined April 2019
Don't wanna be here? Send us removal request.
@LeandroJonatad1
Leandro Jonata Oliveira
1 month
RT @SidYadavMD: A dream come true- published in @Nature Using CRISPR–Cas9, we analyzed the functional effect of >6500 missense Variants o…
0
125
0
@LeandroJonatad1
Leandro Jonata Oliveira
1 month
RT @BMJOncology: The financial incentives of the Oncology-Industrial Complex result in greater patient volumes, decreasing time for clinic…
0
4
0
@LeandroJonatad1
Leandro Jonata Oliveira
2 months
RT @oncodaily: A Portrait of Germline Pathogenic Variants in Breast Cancer Genes in Brazil @rdienstmann @FrontOn
0
1
0
@LeandroJonatad1
Leandro Jonata Oliveira
2 months
RT @NEJMEvidence: How do we make sense of two “negative” trials in @NEJM and a “positive” meta-analysis of the two trials in NEJM Evidence?…
0
282
0
@LeandroJonatad1
Leandro Jonata Oliveira
2 months
RT @VKaklamani: My take aways from #sabcs24: anthra beneficial for RS>31; imlunestrant active as single agent unclear what combo data means…
0
32
0
@LeandroJonatad1
Leandro Jonata Oliveira
2 months
RT @DrHBurstein: Important presentation on anthracyclines and outcomes in TAILORx by OncotypeDX score. Anthracycline chemo benefit over TC…
0
55
0
@LeandroJonatad1
Leandro Jonata Oliveira
2 months
RT @DrHBurstein: 2024 proving a big year for palbociclib in MBC - Inavolisib approval with palbo - PATINA @Otto_DFCI shows major benefit i…
0
13
0
@LeandroJonatad1
Leandro Jonata Oliveira
2 months
RT @GBECAMConnect: 🇧🇷✨ Another study from the AC Camargo team, presented by Giulia Zanetta! 🧬 Germline Mutations in Early Triple-Negative…
0
3
0
@LeandroJonatad1
Leandro Jonata Oliveira
2 months
RT @PedroExman: Very interesting initial session at #SABCS2024 that encompasses the daily life of patients. At the end of the day: 🚴🏻‍♀️…
0
7
0
@LeandroJonatad1
Leandro Jonata Oliveira
2 months
RT @VKaklamani: Great opening session of #sabcs24 chaired by Carol Fabian on the role of obesity in breast cancer and how to overcome it. ⁦…
0
8
0
@LeandroJonatad1
Leandro Jonata Oliveira
2 months
RT @GBECAMConnect: Afilie-se ao GBECAM! Faça parte do Grupo Brasileiro de Estudos do Câncer de Mama e colabore com projetos que transformam…
0
2
0
@LeandroJonatad1
Leandro Jonata Oliveira
2 months
RT @GBECAMConnect: ‼️O GBECAM lança o Fundo de Incentivo à Pesquisa (FIP) 2025, com até R$ 200 mil em financiamento para projetos que promo…
0
3
0
@LeandroJonatad1
Leandro Jonata Oliveira
3 months
RT @jamecancerdoc: Current Clinical Utility of Circulating Tumor DNA Testing in Breast Cancer: A Practical Approach | JCO Oncology Practice…
0
32
0
@LeandroJonatad1
Leandro Jonata Oliveira
3 months
RT @DrYukselUrun: 🩸🧬Liquid biopsy detects gene copy number (CN) losses, including PTEN, BRCA1/2, PALB2, and MTAP. High sensitivity observed…
0
10
0
@LeandroJonatad1
Leandro Jonata Oliveira
3 months
RT @GUlyssea: Minha coluna de hoje no Globo sobre a PEC da escala 6x1. Ela pode gerar efeitos opostos aos desejados.
0
184
0
@LeandroJonatad1
Leandro Jonata Oliveira
3 months
RT @acmoorephd: I remember one expert saying #clinicaltrials give patients access to tomorrow's medicines today. I like that. Congratulatio…
0
2
0